MicroRNA 6756 (MIR6756)

MicroRNA 6756 (MIR6756) is a small, single-stranded regulatory RNA molecule, classified as a microRNA, that functions mainly by binding to complementary sequences in the 3' untranslated regions (UTRs) of specific mRNAs, leading to their degradation or translational repression. In castration-resistant prostate cancer (CRPC), miR-6756-5p is overexpressed and negatively regulates the cytokine Interleukin-24 (IL-24), promoting cancer cell proliferation and migration. Experimental inhibition of miR-6756-5p increases IL-24 levels and suppresses malignant phenotypes, suggesting its utility both as a biomarker and a potential therapeutic target in prostate cancer[1][4]. Outside prostate cancer, the broader regulatory role of miR-6756 remains under investigation. There is no evidence of spelling error or that this is an incorrect or invalid molecular target, though it is a relatively novel entity and not broadly characterized in non-cancer contexts[6][1]. No drugs directly approved for targeting MIR6756 exist, but miRNA inhibitors have been used experimentally.

Other names

hsa-mir-6756hsa-miR-6756-5pmicroRNA mir-6756MIR6756

Inhibitors: increase IL-24 expression and suppress proliferation/migration of CRPC cells. Mimics/agonists: decrease IL-24 expression, promoting cell proliferation and migration.